BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20305341)

  • 1. Evaluation of estrogen receptor alpha, estrogen receptor beta, progesterone receptor, and cKIT expression in desmoids tumors and their role in determining treatment options.
    Santos GA; Cunha IW; Rocha RM; Mello CA; Guimarães GC; Fregnani JH; Lopes A
    Biosci Trends; 2010 Feb; 4(1):25-30. PubMed ID: 20305341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for extra-abdominal and abdominal wall desmoids: a 20-year experience at a single institution.
    Huang K; Fu H; Shi YQ; Zhou Y; Du CY
    J Surg Oncol; 2009 Dec; 100(7):563-9. PubMed ID: 19722232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
    Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
    Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
    Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
    Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospho-serine-118 estrogen receptor-alpha expression is associated with better disease outcome in women treated with tamoxifen.
    Murphy LC; Niu Y; Snell L; Watson P
    Clin Cancer Res; 2004 Sep; 10(17):5902-6. PubMed ID: 15355923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor subtypes in ovarian cancer: a clinical correlation.
    Chan KK; Wei N; Liu SS; Xiao-Yun L; Cheung AN; Ngan HY
    Obstet Gynecol; 2008 Jan; 111(1):144-51. PubMed ID: 18165403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor-beta expression in extraabdominal fibromatoses: an analysis of 40 cases.
    Deyrup AT; Tretiakova M; Montag AG
    Cancer; 2006 Jan; 106(1):208-13. PubMed ID: 16333857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.
    Saji S; Omoto Y; Shimizu C; Warner M; Hayashi Y; Horiguchi S; Watanabe T; Hayashi S; Gustafsson JA; Toi M
    Cancer Res; 2002 Sep; 62(17):4849-53. PubMed ID: 12208729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
    Borgquist S; Holm C; Stendahl M; Anagnostaki L; Landberg G; Jirström K
    J Clin Pathol; 2008 Feb; 61(2):197-203. PubMed ID: 18223096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extremity and trunk desmoid tumors: a multifactorial analysis of outcome.
    Merchant NB; Lewis JJ; Woodruff JM; Leung DH; Brennan MF
    Cancer; 1999 Nov; 86(10):2045-52. PubMed ID: 10570430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor alpha, estrogen receptor beta, and progesterone receptor as possible prognostic factor in radically resected gallbladder carcinoma.
    Park JS; Jung WH; Kim JK; Hwang HK; Cho SI; Yoon DS; Chi HS; Kim BR
    J Surg Res; 2009 Mar; 152(1):104-10. PubMed ID: 18394649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor alpha and beta, progesterone receptor, pS2 and HER-2/neu expression delineate different subgroups in ductal carcinoma in situ of the breast.
    Rody A; Diallo R; Poremba C; Speich R; Wuelfing P; Kissler S; Solbach C; Kiesel L; Jackisch C
    Oncol Rep; 2004 Oct; 12(4):695-9. PubMed ID: 15375487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue- and hormone-dependent progesterone receptor distribution in the rat uterus.
    Sahlin L; Masironi B; Akerberg S; Eriksson H
    Reprod Biol Endocrinol; 2006 Sep; 4():47. PubMed ID: 16965620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
    Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
    Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal mapping and quantitative analysis of estrogen-related receptor alpha-1, estrogen receptors alpha and beta and progesterone receptor in the bovine mammary gland.
    Connor EE; Wood DL; Sonstegard TS; da Mota AF; Bennett GL; Williams JL; Capuco AV
    J Endocrinol; 2005 Jun; 185(3):593-603. PubMed ID: 15930184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.
    Yamashita H; Nishio M; Kobayashi S; Ando Y; Sugiura H; Zhang Z; Hamaguchi M; Mita K; Fujii Y; Iwase H
    Breast Cancer Res; 2005; 7(5):R753-64. PubMed ID: 16168121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid hormone receptor expression in male breast cancer.
    Murphy CE; Carder PJ; Lansdown MR; Speirs V
    Eur J Surg Oncol; 2006 Feb; 32(1):44-7. PubMed ID: 16260112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.